Core Viewpoint - 中红医疗 plans to engage in low-risk financial investments and hedging activities in 2026 to enhance financial stability and mitigate risks associated with currency and commodity price fluctuations [1][2][3][5] Group 1: Financial Activities - 中红医疗 intends to use up to 2 billion RMB of idle funds to invest in low-risk financial products with a maximum investment period of 36 months [5] - The company plans to conduct foreign exchange derivative transactions with a maximum balance of 500 million USD to manage currency risk, using its own funds [2][3][4] - The company aims to engage in commodity futures hedging with a total transaction amount not exceeding 50 million RMB, also funded by its own resources [2][3] Group 2: Governance and Approval - The board of 中红医疗 approved several proposals on January 19, 2026, which will be submitted for shareholder approval at the first extraordinary general meeting on February 5, 2026 [1][5] - The proposals include the use of idle funds for low-risk investments, foreign exchange derivative transactions, and commodity futures hedging, with related party transactions requiring abstention from voting by related shareholders [1][2]
股市必读：中红医疗（300981）1月20日主力资金净流出65.05万元